§ Why is MRNA moving today →

Why Moderna (MRNA) Stock Fell 2.2% on November 20, 2026

-2.17%$195.00November 20, 2026 · S&P 500 -3.64%
The short answer

Moderna (MRNA) stock is down 2.2% today, priced at $195.00, while the S&P 500 ETF (SPY) has decreased by 3.6% in the same session. The broad market moved in the same direction by a similar amount, suggesting the drop is largely market-wide. Recent headlines include "Learn Why The Bull Case For Moderna (MRNA) Could Change Following Melanoma Vaccine Trial Results," which may indicate concerns regarding upcoming trial outcomes, potentially influencing investor sentiment. However, there is no single clear catalyst in the news driving the stock movement.

The news behind it

Learn Why The Bull Case For Moderna (MRNA) Could Change Following Melanoma Vaccine Trial Results · Yahoo · Nov 21
Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027 · The Motley Fool · Nov 20
Before you buy or sell
Get a second opinion on MRNA
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when MRNA moves
Price, RSI and volume alerts by email or push. Free plan →

Full market recap for November 20, 2026 · What's moving MRNA today

Written from that session's quote and the headlines listed above. Educational, not financial advice.